Biobanking - Evaluating the Benefits of Public-Private Partnerships

Heli Salminen
Contributor: Heli Salminen
Posted: 02/19/2015

In this interview Heli Salimen-Mankonen, Research Director, Auria Biobank, speaks to Andrea Charles from Pharma IQ about forming and sustaining public-private partnerships and the evaluating the benefits of this collaboration. Pharma IQ: What are the key differences between the sectors? H Salimen-Mankonen: Human biological samples and

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Heli Salminen
Contributor: Heli Salminen
Posted: 02/19/2015

EVENTS OF INTEREST

Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018